TY - JOUR
T1 - Clinical and genetic characterization of leukoencephalopathies in adults
AU - Lynch, David S.
AU - Rodrigues Brandão De Paiva, Anderson
AU - Zhang, Wei Jia
AU - Bugiardini, Enrico
AU - Freua, Fernando
AU - Tavares Lucato, Leandro
AU - Macedo-Souza, Lucia Inês
AU - Lakshmanan, Rahul
AU - Kinsella, Justin A.
AU - Merwick, Aine
AU - Rossor, Alexander M.
AU - Bajaj, Nin
AU - Herron, Brian
AU - McMonagle, Paul
AU - Morrison, Patrick J.
AU - Hughes, Deborah
AU - Pittman, Alan
AU - Laurà, Matilde
AU - Reilly, Mary M.
AU - Warren, Jason D.
AU - Mummery, Catherine J.
AU - Schott, Jonathan M.
AU - Adams, Matthew
AU - Fox, Nick C.
AU - Murphy, Elaine
AU - Davagnanam, Indran
AU - Kok, Fernando
AU - Chataway, Jeremy
AU - Houlden, Henry
PY - 2017/5/1
Y1 - 2017/5/1
N2 - Leukodystrophies and genetic leukoencephalopathies are a rare group of disorders leading to progressive degeneration of cerebral white matter. They are associated with a spectrum of clinical phenotypes dominated by dementia, psychiatric changes, movement disorders and upper motor neuron signs. Mutations in at least 60 genes can lead to leukoencephalopathy with often overlapping clinical and radiological presentations. For these reasons, patients with genetic leukoencephalopathies often endure a long diagnostic odyssey before receiving a definitive diagnosis or may receive no diagnosis at all. In this study, we used focused and whole exome sequencing to evaluate a cohort of undiagnosed adult patients referred to a specialist leukoencephalopathy service. In total, 100 patients were evaluated using focused exome sequencing of 6100 genes. We detected pathogenic or likely pathogenic variants in 26 cases. The most frequently mutated genes were NOTCH3, EIF2B5, AARS2 and CSF1R. We then carried out whole exome sequencing on the remaining negative cases including four family trios, but could not identify any further potentially diseasecausing mutations, confirming the equivalence of focused and whole exome sequencing in the diagnosis of genetic leukoencephalopathies. Here we provide an overview of the clinical and genetic features of these disorders in adults.
AB - Leukodystrophies and genetic leukoencephalopathies are a rare group of disorders leading to progressive degeneration of cerebral white matter. They are associated with a spectrum of clinical phenotypes dominated by dementia, psychiatric changes, movement disorders and upper motor neuron signs. Mutations in at least 60 genes can lead to leukoencephalopathy with often overlapping clinical and radiological presentations. For these reasons, patients with genetic leukoencephalopathies often endure a long diagnostic odyssey before receiving a definitive diagnosis or may receive no diagnosis at all. In this study, we used focused and whole exome sequencing to evaluate a cohort of undiagnosed adult patients referred to a specialist leukoencephalopathy service. In total, 100 patients were evaluated using focused exome sequencing of 6100 genes. We detected pathogenic or likely pathogenic variants in 26 cases. The most frequently mutated genes were NOTCH3, EIF2B5, AARS2 and CSF1R. We then carried out whole exome sequencing on the remaining negative cases including four family trios, but could not identify any further potentially diseasecausing mutations, confirming the equivalence of focused and whole exome sequencing in the diagnosis of genetic leukoencephalopathies. Here we provide an overview of the clinical and genetic features of these disorders in adults.
KW - imaging
KW - leukodystrophy
KW - neurodegeneration
KW - white matter lesion
UR - http://www.scopus.com/inward/record.url?scp=85019582044&partnerID=8YFLogxK
U2 - 10.1093/brain/awx045
DO - 10.1093/brain/awx045
M3 - Article
C2 - 28334938
AN - SCOPUS:85019582044
SN - 0006-8950
VL - 140
SP - 1204
EP - 1211
JO - Brain: a journal of neurology
JF - Brain: a journal of neurology
IS - 5
ER -